Jul 05, 2017 13:00 pm UTC| Business
NEW YORK, July 05, 2017 -- ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotechnology company, today announced promising results from its Phase 1b pertussis vaccine clinical trial conducted in Stockholm, Sweden,...
Jul 05, 2017 13:00 pm UTC| Business
MIAMI, July 05, 2017 -- Kisses from Italy, a U.S. based fast-casual restaurant chain and now franchisor, is proud to announce the launching of its national franchising program and the completion and sale of the first...
Grace Announces Release Date for Second Quarter 2017 Results
Jul 05, 2017 13:00 pm UTC| Business
COLUMBIA, Md., July 05, 2017 -- W. R. Grace Co. (NYSE:GRA) will release its second quarter 2017 financial results at 6:00 a.m. ET on Thursday, July 27, 2017. A company-hosted conference call and webcast will follow at...
Medecision Recognized for the Third Year in a Row on Healthcare Informatics’ 2017 HCI100 List
Jul 05, 2017 13:00 pm UTC| Business
WAYNE, Pa., July 05, 2017 -- Medecision, the leader in population health management solutions for risk-bearing entities, announced it has been named to the 2017 Healthcare Informatics HCI100 list for the third year in a...
CURE Pharmaceutical Expects Increased Demand for Its Enhanced Transdermal Drug Delivery Platform
Jul 05, 2017 13:00 pm UTC| Business
OXNARD, Calif., July 05, 2017 -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, today announced that it expects...
ABcann Global Announces Inclusion on the Horizons Medical Marijuana Life Sciences ETF
Jul 05, 2017 12:55 pm UTC| Business
OTTAWA, July 05, 2017 -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce its inclusion in the Horizons Medical Marijuana Life Sciences ETF (TSX:HMMJ) (the “ETF”). The ETF is...
Jul 05, 2017 12:50 pm UTC| Business
MEDFORD, N.Y., July 05, 2017 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has received approval for commercial use in...